Baseline and decline in device‐derived activity level predict risk of death and heart failure in patients with an ICD for primary prevention
dc.contributor.author | Jamé, Sina | |
dc.contributor.author | Cascino, Tom | |
dc.contributor.author | Yeow, Raymond | |
dc.contributor.author | Ananwattanasuk, Teetouch | |
dc.contributor.author | Ghannam, Michael | |
dc.contributor.author | Coatney, John | |
dc.contributor.author | Shantha, Ghanshyam | |
dc.contributor.author | Chung, Eugene H. | |
dc.contributor.author | Saeed, Mohammed | |
dc.contributor.author | Cunnane, Ryan | |
dc.contributor.author | Crawford, Thomas | |
dc.contributor.author | Latchamsetty, Rakesh | |
dc.contributor.author | Ghanbari, Hamid | |
dc.contributor.author | Chugh, Aman | |
dc.contributor.author | Pelosi, Frank | |
dc.contributor.author | Bogun, Frank | |
dc.contributor.author | Oral, Hakan | |
dc.contributor.author | Jongnarangsin, Krit | |
dc.date.accessioned | 2020-09-02T14:59:41Z | |
dc.date.available | WITHHELD_12_MONTHS | |
dc.date.available | 2020-09-02T14:59:41Z | |
dc.date.issued | 2020-08 | |
dc.identifier.citation | Jamé, Sina ; Cascino, Tom; Yeow, Raymond; Ananwattanasuk, Teetouch; Ghannam, Michael; Coatney, John; Shantha, Ghanshyam; Chung, Eugene H.; Saeed, Mohammed; Cunnane, Ryan; Crawford, Thomas; Latchamsetty, Rakesh; Ghanbari, Hamid; Chugh, Aman; Pelosi, Frank; Bogun, Frank; Oral, Hakan; Jongnarangsin, Krit (2020). "Baseline and decline in device‐derived activity level predict risk of death and heart failure in patients with an ICD for primary prevention." Pacing and Clinical Electrophysiology 43(8): 775-780. | |
dc.identifier.issn | 0147-8389 | |
dc.identifier.issn | 1540-8159 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/156452 | |
dc.description.abstract | BackgroundImplanted defibrillators are capable of recording activity data based on company‐specific proprietary algorithms. This study aimed to determine the prognostic significance of baseline and decline in device‐derived activity level across different device companies in the real world.MethodsWe performed a retrospective cohort study of patients (n = 280) who underwent a defibrillator implantation (Boston, Medtronic, St. Jude, and Biotronik) for primary prevention at the University of Michigan from 2014 to 2016. Graphical data obtained from device interrogations were retrospectively converted to numerical data. The activity level averaged over a month from a week postimplantation was used as baseline. Subsequent weekly average activity levels (SALs) were standardized to this baseline. SAL below 59.4% was used as a threshold to group patients. All‐cause mortality and death/heart failure were the primary end‐points of this study.ResultsFifty‐six patients died in this study. On average, they experienced a 50% decline in SAL prior to death. Patients (n = 129) who dropped their SAL below threshold were more likely to be older, male, diabetic, and have more symptomatic heart failure. They also had a significantly increased risk of heart failure/death (hazard ratio [HR] 3.6, 95% confidence interval [95% CI] 2.3‐5.8, P < .0001) or death (HR 4.2, 95% CI 2.2‐7.7, P < .0001) compared to those who had sustained activity levels. Lower baseline activity level was also associated with significantly increased risk of heart failure/death and death.ConclusionSignificant decline in device‐derived activity level and low baseline activity level are associated with increased mortality and heart failure in patients with an ICD for primary prevention. | |
dc.publisher | Wiley Periodicals, Inc. | |
dc.subject.other | device‐derived activity | |
dc.subject.other | defibrillation‐ICD | |
dc.subject.other | outcomes | |
dc.title | Baseline and decline in device‐derived activity level predict risk of death and heart failure in patients with an ICD for primary prevention | |
dc.type | Article | |
dc.rights.robots | IndexNoFollow | |
dc.subject.hlbsecondlevel | Physiology | |
dc.subject.hlbtoplevel | Health Sciences | |
dc.description.peerreviewed | Peer Reviewed | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/156452/2/pace13981.pdf | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/156452/1/pace13981_am.pdf | en_US |
dc.identifier.doi | 10.1111/pace.13981 | |
dc.identifier.source | Pacing and Clinical Electrophysiology | |
dc.identifier.citedreference | Conraads VM, Spruit MA, Braunschweig F, et al. Physical activity measured with implanted devices predicts patient outcome in chronic heart failure. Circ Heart Fail. 2014; 7: 279 ‐ 287. | |
dc.identifier.citedreference | Rosman L, Lampert R, Sears SF, Burg MM. Measuring physical activity with implanted cardiac devices: a systematic review. J Am Heart Assoc. 2018; 7: e008663. | |
dc.identifier.citedreference | Kramer DB, Tsai T, Natarajan P, Tewksbury E, Mitchell SL, Travison TG. Frailty, physical activity, and mobility in patients with cardiac implantable electrical devices. J Am Heart Assoc. 2017; 6: e004659. | |
dc.identifier.citedreference | Vegh EM, Kandala J, Orencole M, et al. Device‐measured physical activity versus six‐minute walk test as a predictor of reverse remodeling and outcome after cardiac resynchronization therapy for heart failure. Am J Cardiol. 2014; 113: 1523 ‐ 1528. | |
dc.identifier.citedreference | Pressler A, Danner M, Esefeld K, et al. Validity of cardiac implantable electronic devices in assessing daily physical activity. Int J Cardiol. 2013; 168: 1127 ‐ 1130. | |
dc.identifier.citedreference | Shoemaker MJ, Cartwright K, Hanson K, Serba D, Dickinson MG, Kowalk A. Concurrent validity of daily activity data from medtronic ICD/CRT devices and the actigraph GT3X triaxial accelerometer: a pilot study. Cardiopulm Phys Ther J. 2017; 28: 3 ‐ 11. | |
dc.identifier.citedreference | Melczer C, Melczer L, Goják I, Oláh A, Ács P. A comparative analysis between external accelerometer and internal accelerometer’s physical activity data from implanted resynchronization devices in patients with heart failure. Eur J Integr Med. 2016; 8 ( suppl 2 ): 18 ‐ 22. | |
dc.identifier.citedreference | Kramer DB, Mitchell SL, Monteiro J, et al. Patient activity and survival following implantable cardioverter‐defibrillator implantation: the ALTITUDE activity study. J Am Heart Assoc. 2015; 4: e001775. | |
dc.identifier.citedreference | Jamé S, Kutyifa V, Polonsky B, et al. Predictive value of device‐derived activity level for short‐term outcomes in MADIT‐CRT. Heart Rhythm. 2017; 14: 1081 ‐ 1086. | |
dc.identifier.citedreference | Tyagi S, Curley M, Berger M, et al. Pacemaker quantified physical activity predicts all‐cause mortality. J Am Coll Cardiol. 2015; 66: 754 ‐ 755. | |
dc.identifier.citedreference | Kadhiresan VA, Pastore J, Auricchio A, et al. A novel method—the activity log index—for monitoring physical activity of patients with heart failure. Am J Cardiol. 2002; 89: 1435 ‐ 1437. | |
dc.identifier.citedreference | Levy WC, Mozaffarin D, Linker DT, et al. The Seattle Heart Failure Model prediction of survival in heart failure. Circulartion. 2006; 113: 1424 ‐ 1433. | |
dc.identifier.citedreference | Cleland JGF, Daubert JC, Erdmann E, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005; 352: 1539 ‐ 1549. | |
dc.identifier.citedreference | Gulati SK, McKenzie J, Crossley G, Papp MA, Sims J, Andriulli J. Device measured physical activity: is it the new 6‐minute hall walk? J Cardiac Failure. 2009; 15: S119 ‐ S120. | |
dc.identifier.citedreference | Moss AJ, Hall WJ, Cannom DS, et al. Cardiac‐resynchronization therapy for the prevention of heart‐failure events. N Engl J Med. 2009; 361: 1329 ‐ 1338. | |
dc.identifier.citedreference | Zhao S, Chen K, Su Y, et al. Association between patient activity and long‐term cardiac death in patients with implantable cardioverter‐defibrillators and cardiac resynchronization therapy defibrillators. Eur J Prev Cardiol. 2017; 24: 760 ‐ 767. | |
dc.identifier.citedreference | Kramer DB, Jones PW, Rogers T, Mitchell SL, Reynolds MR. Patterns of physical activity and survival following cardiac resynchronization therapy implantation: the ALTITUDE activity study. Europace. 2017; 19: 1841 ‐ 1847. | |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.